ZYTOLIGHT Trademark

Trademark Overview


On Thursday, October 12, 2023, a trademark application was filed for ZYTOLIGHT with the United States Patent and Trademark Office. The USPTO has given the ZYTOLIGHT trademark a serial number of 79383070. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, August 29, 2024. This trademark is owned by ZytoVision GmbH. The ZYTOLIGHT trademark is filed in the Pharmaceutical Products category with the following description:

Medical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for veterinary diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposes, namely, DNA probes, RNA probes and ...
zytolight

General Information


Serial Number79383070
Word MarkZYTOLIGHT
Filing DateThursday, October 12, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, August 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesMedical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for veterinary diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; chemical preparations for veterinary purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic chemical reagents for medical use; chemical preparations for testing blood for blood disorders, tumor diseases, viruses, bacteria, disease diagnosis and detection, organ function, metabolic disorders, endocrine disorders, hormonal disorders, bacteria-based disorders, virus-based disorders, fungal infections for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic chemical test reagents for medical purposes; diagnostic chemical test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; diagnostic testing materials in the nature of diagnostic chemical and biological reagents for medical use; indicators for medical diagnosis in the nature of chemical and biological diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; reagents for use in diagnostic analysis for veterinary purposes; reagents for analytical diagnostic purposes for medical purposes; reagents for analytical diagnostic purposes for veterinary purposes; diagnostic reagents for in-vitro laboratory use for medical purposes; diagnostic reagents for in-vitro laboratory use for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for microbiological analysis for medical purposes; diagnostic reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic analysis for medical purposes; reagents for use in diagnostic tests for medical purposes; diagnostic reagents for use with analyzers for veterinary purposes; diagnostic reagents for use with analyzers for medical purposes; reactants for medical diagnosis; reactants for veterinary diagnosis; veterinary diagnostic reagents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZytoVision GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, November 14, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, November 21, 2023APPLICATION FILING RECEIPT MAILED
Thursday, May 30, 2024ASSIGNED TO EXAMINER
Friday, November 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 30, 2024NON-FINAL ACTION WRITTEN
Friday, June 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 25, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 27, 2024REFUSAL PROCESSED BY IB
Thursday, August 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 29, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, August 29, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, August 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, August 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2024REFUSAL PROCESSED BY MPU